TABLE III.
In this table, we provide our scenario results for treatment sequence length two. The first column represents the query ID. The second column shows the scenario path (middle age, female, breast cancer, and treatment sequence length two). In the second column, S means surgery, Cmeans chemotherapy, Rmeans radiation therapy, andHmeans hormone therapy. Here, treatment paths are mentioned in the ordered initial format. For example, S-Cmeans the patient first used surgery and then used chemotherapy. We present outcomes in the third column, which is divided into breast cancer subsites. The breast cancer subsite columns are further divided intoRC (right censored) andDE (deceased) columns. The “*” symbol means “we can not report the value because of our data reporting restriction.” Empty table cell means “no value is available.”
| Query ID | Scenario Path | Outcomes | |||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| C50.0 | C50.1 | C50.2 | C50.3 | C50.4 | C50.5 | C50.6 | C50.8 | C50.9 | |||||||||||
| RC | DE | RC | DE | RC | DE | RC | DE | RC | DE | RC | DE | RC | DE | RC | DE | RC | DE | ||
| Q2.1 | S-C | * | * | 100 | 41 | 249 | 64 | 138 | 35 | 820 | 263 | 164 | 42 | 20 | * | 502 | 153 | 365 | 152 |
| Q2.2 | S-R | * | * | 156 | 19 | 338 | 53 | 159 | 17 | 1,014 | 121 | 217 | 24 | 21 | * | 547 | 63 | 361 | 53 |
| Q2.3 | S-H | 16 | * | 116 | * | 180 | 16 | 99 | * | 483 | 45 | 117 | * | * | * | 357 | 35 | 277 | 32 |
| Q2.4 | C-S | * | 24 | * | 34 | * | 18 | * | 147 | 78 | 30 | * | * | * | 82 | 45 | 63 | 70 | |
| Q2.5 | C-R | * | * | * | * | * | * | * | * | * | * | * | * | * | 23 | ||||
| Q2.6 | C-H | * | * | * | * | 17 | * | * | * | * | * | * | * | 17 | |||||
| Q2.7 | R-S | * | * | * | * | * | * | * | * | * | * | * | 16 | * | |||||
| Q2.8 | R-C | * | * | * | * | * | * | * | * | 23 | |||||||||
| Q2.9 | R-H | * | * | * | * | * | * | * | |||||||||||
| Q2.10 | H-S | * | * | * | * | * | * | * | 17 | * | * | * | * | * | 17 | * | |||
| Q2.11 | H-C | * | * | * | * | * | * | * | * | * | * | * | |||||||
| Q2.12 | H-R | * | * | * | * | * | * | ||||||||||||